眾合科技(000925.SZ):與杭州城投資本集團有限公司簽署《戰略合作協議》
格隆匯8月27日丨眾合科技(000925.SZ)公佈,近日,公司與杭州城投資本集團有限公司簽訂戰略合作框架協議,旨在融合雙方獨特的場景洞察與技術專長,聚焦於數智化轉型及各自產業領域開展合作。雙方遵循"優勢互補、攜手並進、共創未來"的原則,融合雙方獨特的場景洞察與技術專長,聚焦於數智化轉型及各自產業領域。
本戰略合作協議的簽署是公司踐行"1+2+N"戰略,圍繞數智化轉型,持續深挖市場機遇,聯合戰略合作伙伴共同推動公司數智化產品在數據運營、城市交通智能化、低空經濟等領域的深度應用,形成資源共享、優勢互補、協同發展的良好局面。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.